• The role of vitamin D dificiency in the development of pathology in women of perimenopausal age
en To content

The role of vitamin D dificiency in the development of pathology in women of perimenopausal age

HEALTH OF WOMAN. 2018.5(131):76–79; doi 10.15574/HW.2018.131.76

Kozak Kh. V.
Lviv National Medical University named after Danylo Halytsky
Scientific and medical center «Saint Paraskeva», Lviv

The article presents an analysis of literary sources about contemporary views on the role of vitamin D deficiency in the health problems of women of the perimenopausal period.

According to research data of recent years, vitamin D plays a role not only in the control of calcium-phosphorus metabolism, but also plays a role in the pathogenesis of cardiovascular and neurological diseases, insulin resistance and diabetes, in the development of cancer and autoimmune conditions, especially in women of perimenopausal age. It is important to continue the study of the relationship between vitamin D deficiency and menopausal and menopausal disorders. Currently, the existing principles and effectiveness of the correction of lack of vitamin D in improving the quality of life of women of perimenopausal age are ambiguously assessed, which determines the relevance of this research direction.

Key words: perimenopausal period, insufficiency/deficiency of vitamin D.

REFERENCES

1. Gromova OA, Torshin IYu, Tomilova IK, Oschepkova EV. 2011. Vozmozhna li profilaktika kaltsifikatsii sosudov preparatami kaltsiya i vitamina D3? Ekspertnoe mnenie 3(11):17-24.

2. Malichenko SB, Volkova VA, Halidova KK. 2008. Sistemnyie izmeneniya v klimakterii. Postmenopauznyiy sindrom: defitsit kaltsiya i vitamina D. Klin. gerontologiya 3:54-62.

3. Anderson JL, May HT, Horne BD et al. 2010. Intermountain Heart Collaborative (IHC) Study Group Relation of vitamin Deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am. J. Cardiol. 106(7):963. https://doi.org/10.1016/j.amjcard.2010.05.027; PMid:20854958

4. Povoroznyuk VV, Balatska NL, Muts VY, Klymovytsky F, Synenky O. 2012. Deficyty i niedobory witaminy D w populacji Ukrainy. Standardy Medicine – Pediatriya. (9):584-589.

5. Płudowski P, Karczmarewicz E, Bayer M et al. 2013. Practical guidelines for the supplementation of vitamin D and the treatment of deficits in Central Europe – recommended vitamin D intakes in the general population and groups at risk of vitamin D deficiency. Endokrynol Pol. 64:319-327. https://doi.org/10.5603/EP.2013.0012; PMid:24002961

6. Mercuro G, Zoncu S, Cherchi А, Rosano GМ. 2010. Саn menoраusе bе considered аn independentrisk factor fоr cardiovascular disease? Itаl. Heart J. 2(10):719-727.

7. Rothwell РМ, Howard SC, Dolan Е et al. 2010. Prognostic signifiсаnсе of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet. 37:895-905. https://doi.org/10.1016/S0140-6736(10)60308-X

8. Snezhitskiy VA, Yankovskaya LV, Povorozniuk VV et al. 2012. Vitamin D deficiency/insufficiency among residents of the Western Region of Belarus suffering from cardiovascular pathology. Standarty Medycуne. Pediatria (9):577-582.

9. Wilson PW, Meigs JB. 2008. Cardiometabolic risk: a Framingham perspective. Int. J. Obes. 32(2):17-20. https://doi.org/10.1038/ijo.2008.30; PMid:18469835

10. Garland CF. 2009. Vitamin D for cancer prevention: global perspective. Ann. Epidemiol. 19:468-483. https://doi.org/10.1016/j.annepidem.2009.03.021; PMid:19523595

11. Bikle D. 2009. Nonclassic Actions of Vitamin D. J. Clin. Endocrinol. Metab. 94(1):26-34. https://doi.org/10.1210/jc.2008-1454; PMid:18854395 PMCid:PMC2630868

12. Bellia A, Garcovich C, D’Adamo M et al. 2011. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern. Emerg. Med. 25:34-7.

13. Bucharles S, Barberato SR, Stinghen AEM et al. 2011. Impact of cholecalciferol treatment on biomarkers of inflammation andmyocardial structure in hemodialysis patients without hyperparathyroidism. J. Ren. Nutr. https://doi.org/10.1053/j.jrn.2011.07.001.

14. Chen TC, Lu Z, Holick MF. 2010. Photobiology of Vitamin D. Nutrition and Health: 35-60.

15. Mitchenko OI, Lutay MI. 2007. Dyslipidemia: diagnosis, prevention and treatment. K, Chetverta hvylia:56.

16. Mitri J, Dawson-Hughes B, Hu FB et al. 2011. Effects of vitamin D and calcium supplementation on pancreatic β cell function,insulin sensitivity, and glycemia in adults at high risk of diabetes: The Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am. J. Clin. Nutr. (94):486-494. https://doi.org/10.3945/ajcn.111.011684; PMid:21715514 PMCid:PMC3142723

17. Chagas CEA, Borges MC, Martini LA et al. 2012. Focus on Vitamin D, inflammation and type 2 diabetes. Nutrients. 4(1):52-67. https://doi.org/10.3390/nu4010052; PMid:22347618 PMCid:PMC3277101

18. Sun J. 2010. Vitamin D and mucosal immune function. Curr. Opin. Gastroenterol. (26):591-595. https://doi.org/10.1097/MOG.0b013e32833d4b9f; PMid:20639756 PMCid:PMC2955835

19. Povorozniuk VV, Balatska NI. 2012. Defitsyt vitaminu D u naselennia Ukrainy ta faktory ryzyku yoho rozvytku. Bol. Sustavу. Pozvonochnyk. 4(08).

20. Kezhun LV, Yankovskaya LV, Lyalikov SA, Kurbat MN. 2014. Sutochnyiy profil arterialnogo davleniya pri vospolnenii defitsita/nedostatochnosti vitamina D u zhenschin s arterialnoy gipertenziey v rannem postmenopauzalnom periode. Zhurnal Grodnenskogo gosudarstvennogo meditsinskogo universiteta (3):112-116.

21. Burgaz A, Orsini N, Latsen SC et al. 2011. Blood 25-hydroxyvitamin D concentration and hypertension: a metanalysis. J. Hypertens. (29):636-645. https://doi.org/10.1097/HJH.0b013e32834320f9; PMid:21191311

22. Dekker JM, Girman C, Rhodes T et al. 2005. Metabolic Syndrome and 10-year cardiovascular disease risk in the Hoorn study. Circulation. (112):666-673. https://doi.org/10.1161/CIRCULATIONAHA.104.516948; PMid:16061755

23. Martins D, Wolf M, Pan D et al. 2007. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch. Intern. Med. 167(11):1159-1165. https://doi.org/10.1001/archinte.167.11.1159

24. Aspray TJ, Bowring C, Fraser W, Gittoes N, Javaid MK, Macdonald H, Patel S, Selby P, Tanna N, Francis RM. 2014. National Osteoporosis Society Vitamin D Guideline Summary. Age Ageing. 28. https://doi.org/10.1093/ageing/afu093

25. Rizzoli R, Boonen S, Brandi ML, Bruyère O, Cooper C, Kanis JA, Kaufman JM, Ringe JD, Weryha G, Reginster JY. 2013, Apr. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). Curr Med Res Opin. 29(4):305-13. https://doi.org/10.1185/03007995.2013.766162.766162. Epub 2013 Feb 7.

26. Malichenko SB, Volkova VA, Halidova KK. 2008. Sistemnyie izmeneniya v klimakterii. Postmenopauznyiy sindrom: defitsit kaltsiya i vitamina D. Klin. Gerontologiya. 3:54-62.

27. Gómez de Tejada Romero MJ, Sosa Henríquez M, Del Pino Montes J, Jódar Gimeno E, Quesada Gómez JM, Cancelo Hidalgo MJ, Díaz Curiel J, Mesa Ramos M, Muñoz Torres M, Carpintero Benítez P, Navarro Ceballos C, Valdés y Llorca C, Giner Ruíz V, Blázquez Cabrera JA, García Vadillo JA, Martínez Rodríguez ME, Peña Arrebola A, Palacios Gil-Antuñano S. 2011. Position document on the requirements and optimum levels of vitamin D. Rev. Osteoporos Metab. Miner. 3(1):53-64.

28. Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. 2011. Endocrine Society. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(7):1911-30. https://doi.org/10.1210/jc.2011-0385. Epub 2011 Jun 6.

29. Jablonski KL, Chonchol M, Pierce GL [et al.]. 2011. 25-Hydroxyvitamin D deficiency is associated with inflammation-linkedvascular endothelial dysfunction in middle-aged and older adults. Hypertension 57:63-69. https://doi.org/10.1161/HYPERTENSIONAHA.110.160929; PMid:21115878 PMCid:PMC3020150

30. Shylin DE. 2010. Vitaminhormon D v klinitsi XXI stolittia: pleiotropni efekty i laboratorna otsinka. Klinichna laboratorna diahnostyka 12:17-23.

31. Bischoff-Ferrari HA, Burckhardt P, Quack-Loetscher K, Gerber B, I’Allemand D, Laimbacher J, Bachmann M, Rizzoli R. 2012. Vitamin D deficiency: Evidence, safety, and recommendations for the Swiss population. Report written by a group of experts on behalf of the Federal Commission for Nutrition (FCN). http://www.iccidd.org/p142000804.html.

32. Hypponen E, Power C. 2007. Hypovitaminosis D in British adults at age 45: nationwide cohort study of dietary and lifestyle predictors. Am. J. Clin. Nutr. 85:860-868. https://doi.org/10.1093/ajcn/85.3.860; PMid:17344510

33. Kendrick J, Targher G, Smits G et al. 2009. 25-Hydroxyvitamin D deficiency is independently associated with cardіovascular disease in the Third National Health and Nutrition Examination Survey. Atheroscl.: 255-260.